MannKind Corp (MNKD): Revenue
$348.97M
Year ended 2025-12-31
$393.63M
Trailing 12 months to 2026-06-30
+51.8%
3-year compound annual growth
+39.9%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $348.97M | +22.2% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $285.50M | +43.5% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $198.96M | +99.4% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $99.77M | +32.2% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $75.44M | +15.8% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $65.14M | +3.3% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $63.04M | +126.3% | 2021-02-25, From 2019-01-01 |
| 2018-12-31 | $27.86M | +137.2% | 2020-02-25, From 2018-01-01 |
| 2017-12-31 | $11.74M | -93.3% | 2019-02-26, From 2017-01-01 |
| 2016-12-31 | $174.76M | n/a | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $0 | n/a | 2016-03-15, From 2015-01-01 |
| 2014-12-31 | $0 | n/a | 2016-03-15, From 2014-01-01 |
| 2013-12-31 | $0 | -100.0% | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | $35.0K | -30.0% | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | $50.0K | -46.2% | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | $93.0K | n/a | 2013-03-18, From 2010-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| MannKind Corp (MNKD) | 2025-12-31 | $348.97M | +22.2% |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | $372.07M | +123.4% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | $386.01M | +6.8% |
| CorMedix Inc. (CRMD) | 2025-12-31 | $311.71M | +617.0% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $407.32M | +22.1% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $297.18M | +11.6% |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $296.15M | -15.7% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $411.33M | +14.7% |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $291.85M | +43.7% |
Compare MNKD, ARQT, SVA, CRMD side by side · Screen every company in Pharmaceutical Preparations ↗